Copper induced neurobehavioral features of Parkinson’s disease and oxidative stress and their abatement by Eugenol
Objective: The aim of this study was to evaluate impact of copper intoxication (10 mg/kg B.W) for 3 days on locomotor performance and oxidative status,…Management of Cervical Dystonia & Spastic Paresis with Botulinum Neurotoxin-A: results from the INPUT survey
Objective: To describe current practices among physicians using botulinum toxin-A (BoNT-A) to treat spastic paresis (SP) and cervical dystonia (CD). Background: BoNT-A is an effective…A novel phasic and restricted basal ganglia thalamocortical subcircuitry model
Objective: To advance a novel basal ganglia thalamocortical (BGTC) model that accounts for GPi as a tonic-burst mode regulator of the thalamus and for restricted…Stiff-person spectrum disorders in Russia: a retrospective analysis of 20 cases
Objective: We aimed to analyze clinical and immunologic features of a cohort of stiff-person spectrum disorder (SPSD) patients, who have been clinically managed by us…Bilateral vocal cord paralysis associated with idiopathic Parkinson’s disease
Objective: We present two cases of bilateral vocal cord paralysis (BVCP) associated with idiopathic Parkinson’s disease (iPD). Background: BVCP is a rare complication associated with…Development and Characterization of an Ultrasensitive Assay Platform for Detection of PD Associated alpha-Synuclein Oligomers in Human Blood
Objective: To develop a sensitive, specific and consistent detection of a-SynO in biofluids to provide a reliable biomarker for disease diagnosis, progression, and a theranostic…Can clinical outputs predict BDNF levels in people with Parkinson’s disease?
Objective: To modelling the relationship between Brain-Derived Neurotrophic Factor (BDNF) levels and clinical variables (stages of disease and cognition) in people with Parkinson's disease (PD).…Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease
Objective: The aim of our study is to examine the relation of alexithymia with cognition and depression in non-demented patients with Parkinson's disease (PD). Background:…How Parkinson’s Disease Affects Working Memory
Objective: Our study designed to (1) measure working memory via verbal Digit Span in Parkinson’s patients without mild cognitive impairment (MCI) (2) determine how dopaminergic…Gender differenes in cognitive functioning in de novo Parkinson’s disease patients
Objective: To clarify the differences in cognitive functioning across different cognitive domains, between male and female de novo PD patients. Background: Parkinson’s disease (PD) is…
- « Previous Page
- 1
- …
- 131
- 132
- 133
- 134
- 135
- …
- 149
- Next Page »